Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 287 results found. Search for [ AstraZeneca COVID-19 vaccine efficacy ]

Results 1 to 21 of 287
Reuters
June 10, 2021
India has not granted indemnity to any COVID-19 vaccine maker, but the sources said the government was having a change of heart


Reuters
May 27, 2021
The Indian Council of Medical Research (ICMR) will review 3,000-5,000 people above 45 years of age, of which up to 80% will be those who have taken the AstraZeneca vaccine made locally by the Serum Institute of India


BusinessToday.In
May 24, 2021
A guidance document on WHO website, updated last week, showed that Bharat Biotech submitted expression of interest for EUL on April 19.


BusinessToday.In
May 23, 2021
Efficacy against COVID-19-linked disease averaged around 85% after a full course, increasing to almost 100% protection against severe disease, hospitalisation or death, say University of Florida researchers


Reuters
May 23, 2021
A study by Public Health England found the Pfizer-BioNTech vaccine was 88% effective against the coronavirus variant first found in India


Reuters
May 22, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects


Reuters
May 21, 2021
Moderna is the fourth COVID-19 vaccine to be approved in South Korea, following doses developed by AstraZeneca Plc , Pfizer Inc and Johnson & Johnson, said Kim


Reuters
May 20, 2021
Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine rollouts, generating a lot of data about the use of the shots in real world settings


Shailendra Shukla
New Delhi, May 15, 2021
Extension of gap between Covishield doses 'reasonable approach', says Dr FauciAmid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'. He said that if one is in a situation that India finds itself in currently, then one would have to try and figure out other ways to get as many as possible vaccinated. The comments come after the government announced on Thursday that the gap betwe...


Reuters
May 14, 2021
The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said the manufacturing capacity for Sputnik V was increasing globally as new manufacturers come on board.


Reuters
May 11, 2021
PHE said the study was the first on protection against mortality from the AstraZeneca vaccine based on data from a real world setting


PTI
May 8, 2021
While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues


Reuters
May 7, 2021
A WHO emergency listing is a signal to national regulators on a product's safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries


Reuters
April 30, 2021
This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University


PTI
April 28, 2021
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3


Reuters
April 19, 2021
The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel's largest healthcare provider, Clalit


Reuters
April 19, 2021
Sarah Walters, AstraZeneca's Austria country manager said so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were \"too small to draw final conclusions\"


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PTI
April 9, 2021
Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PAGES 1 OF 15  12345